Linked Life Data

17481947

Source:http://linkedlifedata.com/resource/pubmed/id/17481947

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17481947rdf:typepubmed:Citationlld:pubmed
pubmed-article:17481947lifeskim:mentionsumls-concept:C1257890lld:lifeskim
pubmed-article:17481947lifeskim:mentionsumls-concept:C0239307lld:lifeskim
pubmed-article:17481947lifeskim:mentionsumls-concept:C0018801lld:lifeskim
pubmed-article:17481947lifeskim:mentionsumls-concept:C0007189lld:lifeskim
pubmed-article:17481947lifeskim:mentionsumls-concept:C0733755lld:lifeskim
pubmed-article:17481947lifeskim:mentionsumls-concept:C0264716lld:lifeskim
pubmed-article:17481947lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:17481947lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:17481947lifeskim:mentionsumls-concept:C1710187lld:lifeskim
pubmed-article:17481947lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:17481947pubmed:issue6-7lld:pubmed
pubmed-article:17481947pubmed:dateCreated2007-5-14lld:pubmed
pubmed-article:17481947pubmed:abstractTextTherapy has improved the survival of heart failure (HF) patients. However, many patients progress to advanced chronic HF (ACHF). We propose a practical clinical definition and describe the characteristics of this condition. Patients that are generally recognised as ACHF often exhibit the following characteristics: 1) severe symptoms (NYHA class III to IV); 2) episodes with clinical signs of fluid retention and/or peripheral hypoperfusion; 3) objective evidence of severe cardiac dysfunction, shown by at least one of the following: left ventricular ejection fraction<30%, pseudonormal or restrictive mitral inflow pattern at Doppler-echocardiography; high left and/or right ventricular filling pressures; elevated B-type natriuretic peptides; 4) severe impairment of functional capacity demonstrated by either inability to exercise, a 6-minute walk test distance<300 m or a peak oxygen uptake<12-14 ml/kg/min; 5) history of >1 HF hospitalisation in the past 6 months; 6) presence of all the previous features despite optimal therapy. This definition identifies a group of patients with compromised quality of life, poor prognosis, and a high risk of clinical events. These patients deserve effective therapeutic options and should be potential targets for future clinical research initiatives.lld:pubmed
pubmed-article:17481947pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17481947pubmed:languageenglld:pubmed
pubmed-article:17481947pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17481947pubmed:citationSubsetIMlld:pubmed
pubmed-article:17481947pubmed:statusMEDLINElld:pubmed
pubmed-article:17481947pubmed:issn1388-9842lld:pubmed
pubmed-article:17481947pubmed:authorpubmed-author:BöhmMichaelMlld:pubmed
pubmed-article:17481947pubmed:authorpubmed-author:McMurrayJohn...lld:pubmed
pubmed-article:17481947pubmed:authorpubmed-author:FraserAlan...lld:pubmed
pubmed-article:17481947pubmed:authorpubmed-author:MetraMarcoMlld:pubmed
pubmed-article:17481947pubmed:authorpubmed-author:GavazziAntone...lld:pubmed
pubmed-article:17481947pubmed:authorpubmed-author:DargieHenryHlld:pubmed
pubmed-article:17481947pubmed:authorpubmed-author:MohacsiPaulPlld:pubmed
pubmed-article:17481947pubmed:authorpubmed-author:DicksteinKenn...lld:pubmed
pubmed-article:17481947pubmed:authorpubmed-author:JaarsmaTinyTlld:pubmed
pubmed-article:17481947pubmed:authorpubmed-author:KomajdaMichel...lld:pubmed
pubmed-article:17481947pubmed:authorpubmed-author:PonikowskiPio...lld:pubmed
pubmed-article:17481947pubmed:authorpubmed-author:AnkerStefanSlld:pubmed
pubmed-article:17481947pubmed:authorpubmed-author:BrutsaertDirk...lld:pubmed
pubmed-article:17481947pubmed:authorpubmed-author:BerghClaes-Ha...lld:pubmed
pubmed-article:17481947pubmed:authorpubmed-author:PitsisAntonis...lld:pubmed
pubmed-article:17481947pubmed:authorpubmed-author:Heart...lld:pubmed
pubmed-article:17481947pubmed:issnTypePrintlld:pubmed
pubmed-article:17481947pubmed:volume9lld:pubmed
pubmed-article:17481947pubmed:ownerNLMlld:pubmed
pubmed-article:17481947pubmed:authorsCompleteYlld:pubmed
pubmed-article:17481947pubmed:pagination684-94lld:pubmed
pubmed-article:17481947pubmed:dateRevised2011-6-8lld:pubmed
pubmed-article:17481947pubmed:meshHeadingpubmed-meshheading:17481947...lld:pubmed
pubmed-article:17481947pubmed:meshHeadingpubmed-meshheading:17481947...lld:pubmed
pubmed-article:17481947pubmed:meshHeadingpubmed-meshheading:17481947...lld:pubmed
pubmed-article:17481947pubmed:meshHeadingpubmed-meshheading:17481947...lld:pubmed
pubmed-article:17481947pubmed:meshHeadingpubmed-meshheading:17481947...lld:pubmed
pubmed-article:17481947pubmed:meshHeadingpubmed-meshheading:17481947...lld:pubmed
pubmed-article:17481947pubmed:meshHeadingpubmed-meshheading:17481947...lld:pubmed
pubmed-article:17481947pubmed:articleTitleAdvanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology.lld:pubmed
pubmed-article:17481947pubmed:affiliationSection of Cardiovascular Diseases, Department of Experimental and Applied Medicine, University of Brescia, Italy. metramarco@libero.it <metramarco@libero.it>lld:pubmed
pubmed-article:17481947pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17481947pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17481947lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17481947lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17481947lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17481947lld:pubmed